Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,708 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Recruiting

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

NCT06389136

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Cahaba Dermatology & Skin Health Center /ID# 263855 Birmingham, Alabama, United States
  • One Of A Kind Clinical Research Center - Scottsdale /ID# 278675 Scottsdale, Arizona, United States
  • Clinical Trials Institute - Northwest Arkansas /ID# 267290 Fayetteville, Arkansas, United States
  • Exalt Clinical Research /ID# 281611 Chula Vista, California, United States
View all 128 locations
View Trial Details
Recruiting

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

NCT07112378

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +11 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • GI Care for Kids LLC Atlanta, Georgia, United States
View Trial Details
Recruiting

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

NCT07230860

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • First OC Dermatology Fountain Valley, California, United States
  • University of California Los Angeles - Division of Dermatology Los Angeles, California, United States
  • Southern California Dermatology Santa Ana, California, United States
  • Driven Research LLC Miami, Florida, United States
View all 62 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

NCT06241118

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • University of Alabama at Birmingham- Site Number : 8401267 Birmingham, Alabama, United States
  • Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States
  • Arkansas Dermatology - North Little Rock- Site Number : 8401244 North Little Rock, Arkansas, United States
  • Encino Research Center- Site Number : 8401042 Encino, California, United States
View all 150 locations
View Trial Details
Recruiting

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

NCT06504160

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • University of California, San Diego: Dermatology Clinical Trials Unit San Diego, California, United States
  • National Jewish Health: Division of Pediatric Allergy and Clinical Immunology Denver, Colorado, United States
  • Northwestern University Feinberg School of Medicine: Department of Dermatology Chicago, Illinois, United States
  • New York University Langone Health: Department of Pediatric Allergy and Immunology New York, United States
View Trial Details
Recruiting

A Study of CDX-622 in Participants With Mild to Moderate Asthma

NCT07330778

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • The University of Kansas Medical Center Kansas City, Kansas, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Pittsburgh Asthma and Environmental Lung Health Institute at UPMC Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria

NCT07680413

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +9 more
Locations
  • Vaishnavis skin Care & Cosmetic Ahmedabad, Gujarat, India
  • Matis Multispeciality Hospital Ahmedabad, Gujarat, India
  • L. G. Hospital Ahmedabad, Gujarat, India
  • Jupiter Hospital and Research Centre Vadodara, Gujarat, India
View all 40 locations
View Trial Details

Related conditions